Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;83(3):332-341.
doi: 10.15288/jsad.2022.83.332.

Predicting the Onset of Opioid Use Disorder in the Swedish General Population

Affiliations

Predicting the Onset of Opioid Use Disorder in the Swedish General Population

Kenneth S Kendler et al. J Stud Alcohol Drugs. 2022 May.

Abstract

Objective: Given the public health importance of opioid use disorder (OUD), we sought to understand better its risk predictors in the Swedish general population.

Method: We examined the Swedish population, born 1950-1970 (n = 2,092,359), and followed through 2018. Using Cox, logistic, and co-sibling models, we explored associations between a wide range of putative risk factors and a first onset of OUD--assessed through medical, criminal, and pharmacy registers--in the entire cohort and in the cohort wherein prior cases of drug use disorder (DUD) were censored.

Results: OUD was predicted by the following four risk factor domains: (a) externalizing syndromes, especially prior non-opioid DUD; (b) psychopathology; (c) psychosocial factors, including social class and immigrant and marital status; and (d) serious injuries and pain diagnoses. When predicting OUD as the first form of DUD, the importance of pain diagnoses as a predictor increased. Co-sibling analyses suggested that the association of some of these risk factors with OUD onset was likely largely causal, whereas others were a mixture of causal effects and familial confounding. An aggregate risk score from these individual risk factors had reasonable receiver operating characteristic (ROC) curve performance.

Conclusions: OUD is a multifactorial syndrome for which risk can be meaningfully predicted by prior externalizing syndromes, internalizing and psychotic psychopathology, indicators of psychosocial status, and predictors of pain diagnoses. Some important differences were seen in the prediction of any OUD onset versus OUD onset as the first form of DUD. Much of the effect of these predictors appear, in co-sibling analyses, to likely reflect causal influences.

PubMed Disclaimer

Figures

Figure 1A.
Figure 1A.
Upper panel: In entire cohort: Risk of opioid use disorder (OUD) on the y-axis as a function of the decile of the risk score (on the x-axis) calculated from an analysis of the entire cohort. Lower panel: Excluding individuals with non-opioid drug use disorder: A receiver operator curve for the risk score for the prediction of opioid use disorder (OUD) calculated from an analysis of the entire cohort (solid line) compared with the null (dotted line). Sensitivity of the score is on the y-axis and 1-specificity is on the x-axis. The area under the curve (AUC) value is 0.708.
Figure 1B.
Figure 1B.
Upper panel: Risk of opioid use disorder (OUD) on the y-axis as a function of the decile of the risk score (on the x-axis) calculated from an analysis of the cohort censoring all cases with prior non-opioid drug use disorder. Lower panel: A receiver operator characteristic curve for the risk score for the prediction of OUD calculated from an analysis of the cohort censoring all cases with prior non-opioid drug use disorder (solid line) compared with the null (dotted line). Sensitivity of the score is on the y-axis and 1-specificity is on the x-axis. The area under the curve (AUC) value is 0.745.

Similar articles

References

    1. Andersson L., Håkansson A., Krantz P., Johnson B. Investigating opioid-related fatalities in southern Sweden: Contact with care-providing authorities and comparison of substances. Harm Reduction Journal. 2020;17 Article no. 5. doi:10.1186/s12954-019-0354-y. - PMC - PubMed
    1. Baldwin G. T., Seth P., Noonan R. K. Continued increases in overdose deaths related to synthetic opioids: Implications for clinical practice. JAMA. 2021;325:1151–1152. doi:10.1001/jama.2021.1169. - PMC - PubMed
    1. Beauchamp G. A., Winstanley E. L., Ryan S. A., Lyons M. S. Moving beyond misuse and diversion: The urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. American Journal of Public Health. 2014;104:2023–2029. doi:10.2105/AJPH.2014.302147. - PMC - PubMed
    1. Blanco C., Wall M. M., Liu S.-M., Olfson M. Toward a comprehensive developmental model of prescription opioid use disorder. Journal of Clinical Psychiatry. 2019;81:19m12775. doi:10.4088/JCP.19m12775. - PubMed
    1. Blanco C., Wall M. M., Okuda M., Wang S., Iza M., Olfson M. Pain as a predictor of opioid use disorder in a nationally representative sample. American Journal of Psychiatry. 2016;173:1189–1195. doi:10.1176/appi.ajp.2016.15091179. - PubMed

Publication types

Substances